妊娠早期或中期SARS-CoV-2感染与后续妊娠结局
这项回顾性队列研究纳入美国17家医院2020年3月至12月分娩的孕妇,比较妊娠28周前SARS-CoV-2阳性者与同期未阳性者的后续妊娠结局。调整分析显示,阳性组胎儿或新生儿死亡、<37周早产及<37周分娩的妊娠期高血压疾病风险轻度升高,<34周早产、重大先天畸形及小于胎龄儿无差异。
要点
- 妊娠28周前SARS-CoV-2感染与后续胎儿或新生儿死亡风险升高相关(2.9% vs 1.5%;调整RR 1.97;95%CI 1.01-3.85)。
- 妊娠28周前SARS-CoV-2感染与<37周早产风险升高相关(19.6% vs 13.8%;调整RR 1.29;95%CI 1.02-1.63)。
- 妊娠28周前SARS-CoV-2感染与<37周分娩的妊娠期高血压疾病风险升高相关(7.2% vs 4.1%;调整RR 1.74;95%CI 1.19-2.55)。
核心结论
- 妊娠期SARS-CoV-2感染后不良妊娠结局风险轻度增加。
研究设计与样本
- 回顾性队列研究,纳入美国17家医院2020年3月至12月分娩的孕妇。
- 比较妊娠28周前SARS-CoV-2检测阳性且后续住院分娩者与同期同院无阳性检测者,两组均排除<20周分娩。
- 阳性组402例患者(分娩414个胎儿或新生儿),对照组11705例患者。
主要发现
- 调整分析显示,阳性组胎儿或新生儿死亡风险升高(2.9% vs 1.5%;调整RR 1.97;95%CI 1.01-3.85)。
- 调整分析显示,阳性组<37周早产风险升高(19.6% vs 13.8%;调整RR 1.29;95%CI 1.02-1.63)。
- 调整分析显示,阳性组<37周分娩的妊娠期高血压疾病风险升高(7.2% vs 4.1%;调整RR 1.74;95%CI 1.19-2.55)。
- <34周早产、任何重大先天畸形及出生时小于胎龄儿(<第5或<第10百分位)率无差异。
- 妊娠期高血压总体发生率及重度子痫前期发生率无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: SARS-CoV-2 infection during pregnancy is associated with adverse pregnancy outcomes, including fetal death and preterm birth. It is not known whether that risk occurs only during the time of acute infection or whether the risk persists later in pregnancy. OBJECTIVE: This study aimed to evaluate whether the risk of SARS-CoV-2 infection during pregnancy persists after an acute maternal illness. STUDY DESIGN: A retrospective cohort study of pregnant patients with and without SARS-CoV-2 infection delivering at 17 hospitals in the United States between March 2020 and December 2020. Patients experiencing a SARS-CoV-2-positive test at or before 28 weeks of gestation with a subsequent delivery hospitalization were compared with those without a positive SAR-CoV-2 test at the same hospitals with randomly selected delivery days during the same period. Deliveries occurring at <20 weeks of gestation in both groups were excluded. The study outcomes included fetal or neonatal death, preterm birth at <37 weeks of gestation and <34 weeks of gestation, hypertensive disorders of pregnancy (HDP), any major congenital malformation, and size for gestational age of <5th or <10th percentiles at birth based on published standards. HDP that were collected included HDP and preeclampsia with severe features, both overall and with delivery at <37 weeks of gestation. RESULTS: Of 2326 patients who tested positive for SARS-CoV-2 during pregnancy and were at least 20 weeks of gestation at delivery from March 2020 to December 2020, 402 patients (delivering 414 fetuses or neonates) were SARS-CoV-2 positive before 28 weeks of gestation and before their admission for delivery; they were compared with 11,705 patients without a positive SARS-CoV-2 test. In adjusted analyses, those with SARS-CoV-2 before 28 weeks of gestation had a subsequent increased risk of fetal or neonatal death (2.9% vs 1.5%; adjusted relative risk, 1.97; 95% confidence interval, 1.01-3.85), preterm birth at <37 weeks of gestation (19.6% vs 13.8%; adjusted relative risk, 1.29; 95% confidence interval, 1.02-1.63), and HDP with delivery at <37 weeks of gestation (7.2% vs 4.1%; adjusted relative risk, 1.74; 95% confidence interval, 1.19-2.55). There was no difference in the rates of preterm birth at <34 weeks of gestation, any major congenital malformation, and size for gestational age of <5th or <10th percentiles. In addition, there was no significant difference in the rate of gestational hypertension overall or preeclampsia with severe features. CONCLUSION: There was a modest increase in the risk of adverse pregnancy outcomes after SARS-CoV-2 infection.
引用
- Hughes BL, Sandoval GJ, Metz TD, et al. First- or second-trimester SARS-CoV-2 infection and subsequent pregnancy outcomes. Am J Obstet Gynecol. 2022. PMID: 35970201. doi:10.1016/j.ajog.2022.08.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。